Latest period
$64.5B
YoY change
+0.6%
5Y CAGR
+12.0%
Peak year (FY2023)
$70.8B
Latest annual
$67.4B
Total Debt history chart for Pfizer (PFE) from 2016 to 2025
Latest: $67.4B
Total Debt growth chart for Pfizer (PFE) from 2016 to 2025
Latest: +0.6%
Total Debt history table for Pfizer (PFE) from 1985 to 2025
| FY2025 | $67.4B | +0.6% | +$423M | ||
| FY2024 | $67B | -5.4% | -$3.85B | ||
| FY2023 | $70.8B | +103.2% | +$36B | ||
| FY2022 | $34.9B | -5.8% | -$2.14B | ||
| FY2021 | $37B | -3.3% | -$1.28B | ||
| FY2020 | $38.3B | -24.7% | -$12.6B | ||
| FY2019 | $50.8B | +21.8% | +$9.1B | ||
| FY2018 | $41.7B | -2.0% | -$861M | ||
| FY2017 | $42.6B | +3.8% | +$1.54B | ||
| FY2016 | $41.1B | +5.6% | +$2.16B | ||
| FY2015 | $38.9B | +6.0% | +$2.22B | ||
| FY2014 | $36.7B | +0.5% | +$193M | ||
| FY2013 | $36.5B | -2.6% | -$971M | ||
| FY2012 | $37.5B | -3.8% | -$1.48B | ||
| FY2011 | $38.9B | -11.6% | -$5.09B | ||
| FY2010 | $44B | -9.5% | -$4.63B | ||
| FY2009 | $48.7B | +181.6% | +$31.4B | ||
| FY2008 | $17.3B | +31.5% | +$4.14B | ||
| FY2007 | $13.1B | +64.6% | +$5.16B | ||
| FY2006 | $7.98B | -55.5% | -$9.96B | ||
| FY2005 | $17.9B | -3.3% | -$609M | ||
| FY2004 | $18.5B | +27.3% | +$3.97B | ||
| FY2003 | $14.6B | +23.4% | +$2.76B | ||
| FY2002 | $11.8B | +33.1% | +$2.94B | ||
| FY2001 | $8.87B | +63.9% | +$3.46B | ||
| FY2000 | $5.41B | -23.5% | -$1.66B | ||
| FY1999 | $7.07B | +117.2% | +$3.82B | ||
| FY1998 | $3.26B | +9.4% | +$280M | ||
| FY1997 | $2.98B | +1.8% | +$54M | ||
| FY1996 | $2.92B | +1.9% | +$53.5M | ||
| FY1995 | $2.87B | +1.6% | +$44.3M | ||
| FY1994 | $2.82B | +61.4% | +$1.07B | ||
| FY1993 | $1.75B | -4.1% | -$74.3M | ||
| FY1992 | $1.82B | -12.7% | -$264M | ||
| FY1991 | $2.09B | +23.3% | +$395M | ||
| FY1990 | $1.69B | -1.4% | -$24.3M | ||
| FY1989 | $1.72B | +43.7% | +$522M | ||
| FY1988 | $1.19B | +23.9% | +$231M | ||
| FY1987 | $964M | +73.1% | +$407M | ||
| FY1986 | $557M | +9.3% | +$47.3M | ||
| FY1985 | $509M | — | — |
- FY2025$67.4B+0.6%
- FY2024$67B-5.4%
- FY2023$70.8B+103.2%
- FY2022$34.9B-5.8%
- FY2021$37B-3.3%
- FY2020$38.3B-24.7%
- FY2019$50.8B+21.8%
- FY2018$41.7B-2.0%
- FY2017$42.6B+3.8%
- FY2016$41.1B+5.6%
- FY2015$38.9B+6.0%
- FY2014$36.7B+0.5%
- FY2013$36.5B-2.6%
- FY2012$37.5B-3.8%
- FY2011$38.9B-11.6%
- FY2010$44B-9.5%
- FY2009$48.7B+181.6%
- FY2008$17.3B+31.5%
- FY2007$13.1B+64.6%
- FY2006$7.98B-55.5%
- FY2005$17.9B-3.3%
- FY2004$18.5B+27.3%
- FY2003$14.6B+23.4%
- FY2002$11.8B+33.1%
- FY2001$8.87B+63.9%
- FY2000$5.41B-23.5%
- FY1999$7.07B+117.2%
- FY1998$3.26B+9.4%
- FY1997$2.98B+1.8%
- FY1996$2.92B+1.9%
- FY1995$2.87B+1.6%
- FY1994$2.82B+61.4%
- FY1993$1.75B-4.1%
- FY1992$1.82B-12.7%
- FY1991$2.09B+23.3%
- FY1990$1.69B-1.4%
- FY1989$1.72B+43.7%
- FY1988$1.19B+23.9%
- FY1987$964M+73.1%
- FY1986$557M+9.3%
- FY1985$509M—
Total Debt values are taken from Pfizer's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Pfizer (PFE)
According to Pfizer's latest reported financial statements, the company's latest reported total debt is $64.5B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Pfizer (PFE) total debt totalled $67.4B – edged up 0.6% year-over-year.
Pfizer total debt compound annual growth for the 2020–2025 (5 years) window is +12.0%, with mixed annual results across the window.
2023 marks the peak total debt at $70.8B, with the historical low of $509M recorded in 1985.
Pfizer Total Debt by Year
Pfizer Total Debt 2025: $67.4B
In 2025, Pfizer reported total debt of $67.4B, edged up 0.6% from 2024.
Pfizer Total Debt 2024: $67B
Pfizer total debt in 2024 was $67B, declined 5.4% below 2023.
Pfizer Total Debt 2023: $70.8B
2023's total debt for Pfizer came in at $70.8B, surged 103.2% from 2022. This figure represents the highest annual value in the available history.
Pfizer Total Debt 2022: $34.9B
Pfizer posted total debt of $34.9B in 2022, declined 5.8% below 2021.
Pfizer Total Debt 2021: $37B
Pfizer total debt in 2021 was $37B.
See more financial history for Pfizer (PFE).
Sector peers by Total Debt
Healthcare peers of Pfizer (PFE), ranked by their latest total debt
| $78.4B | |
| $69.1B | |
| $54.6B | |
| $50.5B | |
| $47.9B | |
| $42.5B | |
| $40.9B | |
| $20.6B |
- $78.4B
- $69.1B
- $54.6B
- $50.5B
- $47.9B
- $42.5B
- $20.6B
Frequently asked questions
Pfizer (PFE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile6.84% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.